🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the functional and clinical outcom...
Status
Completed
Location
Orthopädie/Traumatologie, University Hospital Basel
Start Date
2020-04-01
Trial ID
NCT04378491
This phase I trial studies the side effects and best dose of ubiquitin-acti...
Status
Recruiting
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2025-03-24
Trial ID
NCT06223542
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
Background: Optic neuritis is a frequent cause of vision loss encountered b...
Status
Unknown
Location
CHU of Martinique
Start Date
2019-06-07
Trial ID
NCT03370965
Treatments Being Tested
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
The goal of this study is to show pattern differences of vasoreactivity and...
Status
Terminated
Location
Hopital Gui de Chauliac -Service de Neurologie
Start Date
2014-06-16
Trial ID
NCT02580669
Treatments Being Tested
This study will evaluate obesity-mediated mechanisms of pancreatic carcinog...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-02-22
Trial ID
NCT05687188
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of leflun...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-05-13
Trial ID
NCT06454383
This phase III trial studies whether adding apalutamide to the usual treatm...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2020-04-16
Trial ID
NCT04134260
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213